PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Univ. of MD School of Medicine to study drug-resistant malaria in Myanmar

Two new NIH awards are among first federal funds for malaria Research in Southeast Asian nation; New PNAS paper identifies key markers for tracking spread of drug-resistant malaria

2012-12-18
(Press-News.org) University of Maryland School of Medicine researchers have launched groundbreaking research into the spread of potentially deadly drug-resistant malaria in the developing Southeast Asian nation of Myanmar, also known as Burma. The scientists, working as part of a large international team coordinated by the World Health Organization (WHO), have identified several promising genetic markers that could be used to develop tests to identify and track the spread of the newest type of drug-resistant malaria in Southeast Asia, including Myanmar. The scientists describe these new candidate markers in an article published online Dec. 17 in the journal the Proceedings of the National Academy of Sciences (PNAS). Additionally, two new National Institutes of Health awards to the University of Maryland School of Medicine are some of the first U.S. federal funds to support the study of malaria in Myanmar. Myanmar, long an isolated sovereign state, ended military rule last year and is gradually opening its doors to the rest of the world. In November, President Obama became the first sitting U.S. president to visit the country.

The University of Maryland School of Medicine researchers will use the new funding to track the spread of artemisinin-resistant malaria and train local investigators in cutting-edge molecular and pharmacology lab practices to help their country cope with the problem. Artemisinin-resistant malaria is a new type of resistant malaria that reacts slowly to the first-line treatment against the deadly disease, the artemisinin group of drugs. Malaria is caused by a parasite transmitted in the bite of a mosquito. The disease causes fevers and other symptoms that can lead to coma and even death. There were 216 million cases of malaria in the world in 2010, according to the WHO, and 655,000 deaths, most of them children in Africa. In Africa, a child dies every minute from malaria, also according to the WHO.

"Myanmar has about three percent of the Southeast Asian population, but about 20 percent of the region's malaria," says principal investigator Christopher Plowe, M.D., professor of medicine, epidemiology and public health and microbiology and immunology, a Howard Hughes Medical Investigator and leader of the Malaria Group at the University of Maryland School of Medicine's Center for Vaccine Development. Dr. Plowe will work with scientists from the Johns Hopkins Bloomberg School of Public Health on this research. "Artemisinins are our newest group of effective anti-malaria drugs, having replaced older drugs that are no longer useful because the malaria parasite developed resistance to them. Artemisinin is our first line of defense against this parasite, representing a huge global investment in the fight against the disease. This emerging form of artemisinin-resistant malaria, while it's still relatively rare, is already causing treatment failures where it first appeared, in Cambodia. The concern is that we'll lose this drug, at an immense cost of human life."

Both new awards from the NIH fund Dr. Plowe's research. One R03 grant from the National Institute of Allergy and Infectious Diseases (NIAID) provides $50,000 each year for two years (NIAID Award Number 1R03AI101680-01). A second, one-time supplement to existing funding from the NIH's Fogarty International Center, is for $50,000 and will support research training on bioethics, pharmacology and molecular lab techniques (FIC Award Number 2D43TW001589). On both projects, Dr. Plowe works closely with subcontractor Myaing Myaing Nyunt, M.D., Ph.D., a Myanmar native and assistant professor of International Health and Clinical Pharmacology at the Johns Hopkins Bloomberg School of Public Health. Dr. Nyunt, who is married to Dr. Plowe, is working in Myanmar currently under an Open Society Institute grant to initiate research and teaching collaborations between the Myanmar Ministry of Health and Johns Hopkins University.

The paper published in PNAS – with Dr. Plowe as senior author, and lead author Shannon Takala Harrison, Ph.D., assistant professor of medicine and epidemiology and public health at the University of Maryland School of Medicine -- is a collaboration with University of Maryland, College Park, scientist Michael Cummings, Ph.D., associate professor in the Center for Bioinformatics and Computational Biology, and other scientists from the United Kingdom and Southeast Asia. The work was funded by the Bill and Melinda Gates Foundation through a grant to the WHO.

In the paper, researchers working in Bangladesh, Western Cambodia and areas of northern Thailand near the border with Myanmar conducted clinical trials of artemisinin efficacy, providing samples and data to Dr. Plowe's team. The samples allowed the team to identify four promising molecular markers in hopes of one day developing a test to quickly and accurately identify artemisinin-resistant malaria. The markers were found by testing mutations throughout the malaria genome to see if they were associated with clinical resistance.

"Standard drug susceptibility tests used in the laboratory are not predictive of the slow parasite clearance observed in patients who are infected with drug resistant parasites in Southeast Asia," says Dr. Takala Harrison, who led the genomic analyses for the PNAS study. "In this study, we were able to correlate the parasite markers with clinical resistance, measured as the amount of time it took patients to clear their infections following treatment with artemisinins."

Using the R03 funding, researchers in Myanmar, led by Dr. Plowe, already are further exploring the two most promising markers identified in the paper, one on chromosome 10 and one on chromosome 13. These scientists are examining samples from previous efficacy studies of artemisinin drugs, testing them for the two markers to see if the results correlate with drug resistance. In another project, researchers have undertaken an international study to see if it is possible to replicate the PNAS-published results on a far larger scale.

"This research is providing us with candidate molecular markers for drug resistance," Dr. Plowe says of the PNAS study. "We are now trying to validate these markers in our research in Myanmar, in part using our R03 funding from NIAID. If these markers turn out to be predictive, we can use them to track the spread of drug resistance and to help guide the malaria control program in affected countries. We want to focus limited resources on artemisinin resistance to try to stop it in its tracks before it spreads."

"The University of Maryland School of Medicine and its Center for Vaccine Development have a strong global research presence, with scientists in dozens of countries," says E. Albert Reece, M.D., Ph.D., M.B.A., vice president for medical affairs at the University of Maryland and John Z. and Akiko K. Bowers Distinguished Professor and dean of the University of Maryland School of Medicine. "Dr. Plowe's exceptional studies in tracking resistant malaria and developing vaccine candidates to prevent it are representative of the mission of the Center for Vaccine Development and the entire School of Medicine — to bring groundbreaking scientific discoveries from the laboratory to the clinic, impacting human health in Baltimore and worldwide."

Myanmar is particularly significant in the study of drug-resistant malaria because malaria cases are found throughout the country, unlike in Thailand, where the center of the nation is malaria-free, forming a potential barrier against the disease's spread. Myanmar's high rate of infection paves a path for resistance to spread to and from neighboring nations, Dr. Plowe explains.

"Our main goals are both to track resistance and also to understand the parasite population structure," says Dr. Plowe. The researchers will examine whether there are populations of the malaria parasite that interbreed or reproduce only with themselves in a given region, but do not spread to other regions. Studying the genetic make-up of those parasites can help scientists understand how resistance spreads to new regions and maybe even how to stop it. The race against the spread of resistance is crucial, he says.

"The artemisinin resistance that we're seeing now is slowing how long it takes to clear the parasite — the infection eventually clears in most cases, it just takes longer," explains Dr. Plowe. "But if artemisinin resistance reaches the stage that resistance to other drugs has — which is to say, total resistance, rendering the older drugs useless — we would expect the same to happen to artemisinins. In addition to a loss of human life, if we lost this most important tool against malaria, the recent momentum for global malaria eradication could quickly evaporate. It takes a long time to develop a drug, and we have nothing on the shelf to replace this class of drugs."

The new awards are particularly significant as some of the first U.S. funds to support health research in Myanmar now that the nation is opening up, Dr. Plowe adds. "Part of the purpose of this grant is to see what the challenges are to doing federally-funded research in Myanmar," he says. The scientists, including Dr. Nyunt, will learn how to navigate the nation's government and bureaucracy to make their research happen.

"These awards are like ice-breakers," says Dr. Plowe. "As we learn, we hope to follow them with more funds and training to increase our work in Myanmar."

### About the University of Maryland School of Medicine Established in 1807, the University of Maryland School of Medicine is the first public medical school in the United States, and the first to institute a residency-training program. The School of Medicine was the founding school of the University of Maryland and today is an integral part of the 11-campus University System of Maryland. On the University of Maryland's Baltimore campus, the School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond. www.medschool.umaryland.edu. END


ELSE PRESS RELEASES FROM THIS DATE:

Bullying by childhood peers leaves a trace that can change the expression of a gene linked to mood

2012-12-18
This press release is available in French. A recent study by a researcher at the Centre for Studies on Human Stress (CSHS) at the Hôpital Louis-H. Lafontaine and professor at the Université de Montréal suggests that bullying by peers changes the structure surrounding a gene involved in regulating mood, making victims more vulnerable to mental health problems as they age. The study published in the journal Psychological Medicine seeks to better understand the mechanisms that explain how difficult experiences disrupt our response to stressful situations. "Many people ...

Immediate health risk must be weighed against radiation-induced cancer risk

2012-12-18
OAK BROOK, Ill. – The lifetime risks of cancer from medical radiation may be overemphasized relative to more immediate health risks, according to a new study published online in the journal Radiology. Radiation exposure from computed tomography (CT) and other medical sources has drawn considerable media attention in recent years. Stories warning of the dangers often focus on the lifetime risk estimates of radiation-induced cancer from repeat examinations. This approach has limitations, said Pari V. Pandharipande, M.D., M.P.H., abdominal and genitourinary imaging specialist ...

A new breed of stable anti-aromatic compound

2012-12-18
AUSTIN, Texas – By synthesizing a stable "antiaromatic" compound, as well as a never before seen intermediate version of that compound, chemists at The University of Texas at Austin have written an important new chapter in the story of modern chemistry. The research was done in collaboration with an international roster of colleagues from Yonsei University in Korea, the University of Hyderbad in India, and Osaka University in Japan. The results were published this week in Nature Chemistry. This particular story began in 1825, when English scientist Michael Faraday ...

Mayo Clinic researchers identify enzyme linked to prostate cancer

2012-12-18
JACKSONVILLE, Fla. — Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic spread of the cancer. Their study, published in the Dec. 18 online edition of Molecular Cancer Research, is the first to link the enzyme PRSS3 to prostate cancer. "This molecule is a protease, which means it digests other molecules. Our data suggests PRSS3 activity changes the environment around prostate cancer cells — perhaps ...

Tax evasion in Greece: Billions earned by high-income professionals go untaxed

2012-12-18
UNIVERSITY OF CALIFORNIA, BERKELEY'S HAAS SCHOOL OF BUSINESS –Wide-scale tax evasion in Greece accounts for 28 billion Euros in unreported taxable income –just among the self-employed, according to a new study, "Tax Evasion Across Industries: Soft Credit Evidence from Greece," by Adair Morse, a visiting assistant professor of finance at Berkeley-Haas. At a tax rate of 40 percent, that's a revenue loss responsible for nearly one-third of Greece's deficit in 2009 or almost 50 percent of the deficit in 2008, according to the study co-authored by Margarita Tsoutsoura, ...

New Cell Phone Blocking Technology May Save Lives in Pennsylvania

2012-12-18
According to statistics compiled by the National Highway Traffic Safety Administration, 416,000 people in the United States were injured and another 3,092 killed in motor vehicle accidents involving a distracted driver in 2010, the last year for which numbers are available. Of all car accidents reported in 2010, approximately 18 percent involved driver distraction. Though driver distraction can take many different forms, texting while driving presents a unique danger because it requires a driver's visual, manual, and cognitive attention. What is worse, the popularity ...

Fatal Myrtle Beach Motorcycle Accident Shows Need for Safe Driving

2012-12-18
Motorcycling is a big hobby in South Carolina. While the state does not have quite the renown that Sturgis does, South Carolina hosts several motorcycle rallies throughout the year and bikers from across the U.S. attend these events. Unfortunately, South Carolina started the 2012 cycling season with a fatal motorcycle accident in Myrtle Beach, which is a reminder of how necessary it is for motorcyclists and the drivers with whom they share the road to practice safe driving habits. Myrtle Beach Motorcycle Accident Myrtle Beach police reported that a motorcyclist from ...

Medicaid Planning: Plan for Long-Term Care to Save Money for Your Family

2012-12-18
Many people have saved for a lifetime in order to leave their home and their savings to their family. However, today it is not enough just to have a will, a health care proxy and a power of attorney in place to protect what you own for your family. Since everyone is living longer, it is important to have a plan in place to shelter what you have so it is not lost to home health care or nursing home costs, but goes to the ones that you love. By making important choices early, there is a road map in place during an emergency. Most people want to stay in their homes as long ...

Bankruptcy Requirements in Maryland

2012-12-18
Although filing for bankruptcy has previously carried with it a negative stigma, times now are different. With a struggling economy, it only makes sense that individuals would struggle as well and often to no fault of their own. After the decision to file for bankruptcy has been made, certain requirements are imposed by the Bankruptcy Abuse Prevention and Consumer Protection act of 2005. Counseling Requirements The first requirement when filing for bankruptcy is to receive pre-bankruptcy counseling. This requirement must actually be completed before bankruptcy has ...

Bankruptcy as a Solution for Maryland Residents

2012-12-18
Bankruptcy is becoming more and more of an attractive option for many Americans. With today's economy, this is no surprise. Bankruptcy no longer has the negative stigma it once had and is now looked at as an option to create a fresh start for those struggling with debt, often because of hard economic times. Providing Relief When in debt, a person often struggles with phone calls and harassment from debt collectors. At first, these phone calls are from the companies themselves and are typically not too invasive. After a while, however, the companies sell the debt and ...

LAST 30 PRESS RELEASES:

Simulating scientists: New tool for AI-powered scientific discovery

Helium in the Earth's core

Study: First female runner could soon break the 4-minute-mile barrier

High dietary fish intake may slow disability progression in MS

UK Armed Forces servicewomen face unique set of hurdles for abortion access/care

Use of strong synthetic opioids during surgery linked to poor composite experience of pain

UK innovation to transform treatment for people with type 2 diabetes worldwide

AI model can read ECGs to identify female patients at higher risk of heart disease

Biological organ ages predict disease risk decades in advance

New manzanita species discovered, already at risk

Giant ice bulldozers: How ancient glaciers helped life evolve

Toward high electro-optic performance in III-V semiconductors

In mouse embryos, sister cells commit suicide in unison

Automatic cell analysis with the help of artificial intelligence

New study highlights need for better care to prevent lung problems after abdominal surgery

Microplastics in ocean linked to disabilities for coastal residents

Biophysical Society announced undergraduate poster award competition winners

Successful strategies for collaborative species conservation

Immune cells may lead to more Parkinson's cases in men

SCAI publishes expert consensus on alternative access for transaortic valve replacement (TAVR)

Humans inherited their flexible joints from the earliest jawed fish

Understanding the world within: Study reveals new insights into phage–bacteria interactions in the gut microbiome

Cold treatment does not appear to protect preterm infants from disability or death caused by oxygen loss, according to NIH-funded study

Pennington Biomedical researchers uncover role of hormone in influencing brain reward pathway and food preferences

Rethinking equity in electric vehicle infrastructure

Lunar Trailblazer blasts off to map water on the moon

Beacon Technology Solutions, Illinois Tech awarded grant to advance far-UVC disinfection research

University of Houston researchers paving the way for new era in medical imaging

High-tech startup CrySyst provides quality-by-control solutions for pharmaceutical, fine chemical industries

From scraps to sips: Everyday biomass produces drinking water from thin air

[Press-News.org] Univ. of MD School of Medicine to study drug-resistant malaria in Myanmar
Two new NIH awards are among first federal funds for malaria Research in Southeast Asian nation; New PNAS paper identifies key markers for tracking spread of drug-resistant malaria